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Abstract
The aim of the study was to establish an optimized protocol of iron dextran administration to pig neonates, which better
meets the iron demand for erythropoiesis. Here, we monitored development of red blood cell indices, plasma iron
parameters during a 28-day period after birth (till the weaning), following intramuscular administration of different
concentrations of iron dextran to suckling piglets. To better assess the iron status we developed a novel mass spectrometry
assay to quantify pig plasma levels of the iron-regulatory peptide hormone hepcidin-25. This hormone is predominantly
secreted by the liver and acts as a negative regulator of iron absorption and reutilization. The routinely used protocol with
high amount of iron resulted in the recovery of piglets from iron deficiency but also in strongly elevated plasma hepcidin-25
levels. A similar protocol with reduced amounts of iron improved hematological status of piglets to the same level while
plasma hepcidin-25 levels remained low. These data show that plasma hepcidin-25 levels can guide optimal dosing of iron
treatment and pave the way for mixed supplementation of piglets starting with intramuscular injection of iron dextran
followed by dietary supplementation, which could be efficient under condition of very low plasma hepcidin-25 level.
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Introduction
Iron deficiency is considered to be the most common
mammalian nutritional deficiency [1] and is most prevalent in
the neonatal period [2]. Neonatal IDA is particularly frequent and
severe in pigs, regardless of the breed and the system of piglet
rearing [3], [4]. Iron scarcity in piglets is the result of interplay of
several distinct risk factors such as low level of iron stores,
increased iron requirements, limited external supply and the
immaturity of molecular mechanisms of iron absorption [5], [6].
For decades pigs have been selected for large litter size, high birth
weight and fast growth, which resulted in greater body blood
volume, red blood cells (RBC) count, and in consequence, in
increased iron demands. Both hepatic iron reserves and the sow’s
milk are therefore nowadays not sufficient to meet iron require-
ments in suckling piglets [3], [4], [7]. Moreover, the molecular
machinery responsible for iron absorption in newborn piglets is
not fully developed, and this may explain a reduced responsiveness
of these animals to oral iron therapy [8], [9]. Consequently, the
use of parenteral injection of exogenous iron to prevent deepening
iron deficiency in suckling piglets has been well documented and is
obligatory in pig breeding [10], [11], [12]. Various iron
supplementation strategies (in terms of time and route of iron
administration as well as the amount and the form of supplemental
iron) have been tested and many of them proved to be beneficial in
correcting IDA in newborn piglets as evaluated by measuring their
RBC indices and serum iron status [10], [11], [12], [13], [14],
[15].
Over the past eleven years major insights have been made into
the role of hepcidin in the tuning of systemic iron homeostasis
[16], [17]. Hepcidin is a peptide hormone, mainly secreted by the
liver, which acts as a negative regulator of iron absorption and its
reutilization by macrophages of the reticuloendothelial system
(RES). By binding to ferroportin, the only known iron exporter,
hepcidin causes ferroportin internalization and degradation, hence
decreasing the absorption of dietary iron by enterocytes and the
release of iron from macrophages that have engulfed senescent
RBCs, into the plasma. Inappropriate low hepcidin levels cause
the iron overload disorders, whereas increased hepcidin expression
leads to anemia due to the insufficient intestinal iron absorption
and iron arrest in the RES [16].
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Considering that hepcidin is up-regulated by high iron
concentrations in the plasma and the liver [16], we aimed in this
study to establish an optimal strategy of iron supplementation in
piglets, which could both improve RBC indices and minimize
dysfunctional induction of hepcidin expression that could poten-
tially have an adverse effect on iron utilization.
The intramuscular injection of large amount of iron dextran to
suckling piglets is a relatively simple therapy, which in general,
efficiently corrects iron deficiency anemia (IDA), widely occurring
in pig neonates, and therefore is routine practice in pig breeding
[10], [11], [12]. We have recently demonstrated that excessive
loading of piglets with iron dextran induces hepcidin expression at
the mRNA level in the liver, and may perturbate the utilization of
iron released from this compound by blocking ferroportin [10],
[20]. It has been well established that after injection, iron dextran
is rapidly taken from plasma and deposited in the reticuloendo-
thelial system [21]. The elemental iron is then released from the
complex with polyisomaltose by macrophages (mainly by Kupffer
cells) and successively re-enters plasma via a ferroportin-dependent
pathway. Next, the blood flow iron is complexed with transferrin
(Tf) and transported to the bone marrow to allow hemoglobin
synthesis. It seems that the optimal iron supplementation in piglets
should meet two main criteria: 1) the delivery of sufficient amount
of iron for erythropoiesis; 2) the avoidance of a dysfunctional
increase in plasma hepcidin levels.
We have recently reported that by both reducing the amount of
supplemented iron and modifying the timing of its dosage, we can
improve the hematological status of piglets while attenuating their
hepatic hepcidin mRNA levels [10]. Here, we have developed a
mass spectrometry assay to quantify bioactive hepcidin-25 in piglet
plasma and assessed different protocols of piglet supplementation
with iron dextran for their ability to stimulate recovery from
neonatal IDA without inducing an unfavorable increase in plasma
hepcidin.
Materials and Methods
Ethics Statement
Use of animals in the experiment and all procedures were
approved by the Second Local Ethical Committee on Animal
Testing at the Institute of Pharmacology in Krakow (permission
no. 975).
Animals, Experimental Design, and Blood Samples
Collection
Experiments were conducted at the pig farm Brzezie belonging
to the National Research Institute of Animal Production (Balice,
Poland). A total of 27 Polish Landrace 6 Polish Large White
piglets housed in standard conditions (approx. 70% humidity and
a temperature of 2262uC in standard cages with straw bedding)
were used in the experiments. During the 28-day experiment sows
were allowed to nurse their piglets. The feed (Prestarter, was
manufactured at the feed mill of the Experimental Station of the
National Research Institute of Animal Production in Brzezie; iron
content 0.75 mg Fe/kg feed mixture) was offered to piglets from
day 7 to day 28. Piglets were taken from 3 litters delivered by 3
multipara sows. They were allotted to one of following experi-
mental groups (9 piglets per group) on the basis of balanced body
weight (b.w.) at birth (Figure 1): A) piglets routinely supplemented
by intramuscular injection with 150 and 40 mg Fe/kg b.w. on
days 3 and 21 postpartum, respectively; B) piglets supplemented
with 37.5 mg Fe/kg b.w. on days 3 and 14 postpartum; C) piglets
supplemented with 37.5 mg Fe/kg b.w. on day 3 postpartum only.
Iron was administered to piglets by intramuscular injection in the
neck in the form of iron dextran (FeDex), a complex of ferric ions
with low molecular weight dextran (Suiferron, Mifarmex Ltd,
Michało´w-Grabina, Poland or Ferran 100, Vet-Agro, Lublin,
Poland). Blood samples for analyses were taken from all piglets on
days 3, 14, 21, and 28 of life. At the same periods all animals were
weighed. Blood was drawn by venipuncture of the jugular vein
(Vena jugularis externa) into tubes coated with heparin or EDTA as
anticoagulants. Heparinized blood was immediately spun down (at
Figure 1. Experimental design scheme. 3 various protocols of iron dextran administration in piglets are indicated as A, B and C. Iron dextran was
injected to piglets on days indicated by arrows. Blood samples were collected on days 3, 14, 21 and 28 after birth. When iron dextran injection and
blood collection fell on the same day, blood was always drawn before iron administration.
doi:10.1371/journal.pone.0064022.g001
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4uC, 2000 rpm, 10 min) to collect plasma. Plasma samples were
aliquoted and stored at 280uC. EDTA-whole blood was used for
immediate hematological analyses.
Hematological Analysis
Red blood cells (RBC) parameters such as RBC count,
hemoglobin level (HGB), hematocrit (HCT), mean cell volume
(MCV), mean corpuscular hemoglobin (MCH), and mean
corpuscular hemoglobin concentration (MCHC) were determined
using an automated AVIDIA 2010 analyzer (Siemens, Germany).
Plasma Iron Parameters
Plasma iron concentration and total iron binding capacity
(TIBC) were determined by colorimetric measurement of the
absorbance of the iron-chromazurol complex at 630 nm (Alpha
Diagnostic, Poland). Percent of transferrin (Tf) saturation by iron
was calculated according to the following formula: TSAT = [-
plasma iron/TIBC]6 100.
Plasma Hepcidin-25 Quantification
Piglet plasma hepcidin-25 measurements were performed by a
combination of weak cation exchange chromatography and time-
of-flight mass spectrometry (WCX-TOF MS), as described
previously for human plasma samples [17], [18], [19]. Peptide
spectra were generated on a Microflex LT matrix-enhanced laser
desorption/ionisation TOF MS platform (BrukerDaltonics). When
piglet samples were applied, this procedure yielded a peak with
mass/charge ratio (m/z) of 2750, which corresponds to the
theoretical mass of pig hepcidin-25 (2749.4 Da), assuming that 4
intra-molecular disulphide bridges are present as is the case for all
other known hepcidin molecules (Figure 2). The identity of this
peak was further confirmed by its specific disappearance from the
mass spectrum by pre-incubation of piglet plasma samples with
anti-hepcidin molecules (data not shown). A synthetic human
hepcidin-25 peptide (Peptide International Inc.) was used as
internal standard for quantification. Piglet plasma hepcidin-25
concentrations were expressed as nmol/L (nM). The lower limit of
detection of this method was 1 nM.
Statistical Analysis
Data are presented as mean values 6 SD. Statistical analysis of
results was performed using one-way analysis of variance (one-way
ANOVA). The significance of differences was verified by Tukey’s
test using Statgraphics 5.1 program (Manugistics, USA). Statisti-
cally significant differences between parameters of piglets from
different groups on a given day of experiment were denoted by
Figure 2. Pig Hepcidin-25 quantification by mass spectrometry. Hepcidin-25 measurements in piglet plasma were performed by peptide
enrichment through weak cation exchange chromatography coupled to time-of-flight mass spectrometry (WCX-TOF MS). Note that quantification is
based on the relative intensity of the piglet hepcidin peak with mass/charge ratio (m/z) of 2750 to that of the synthetic internal standard (IS) that is
spiked in the know concentration of 10 nM to each sample prior to sample work-up. The four spectra illustrate the appearance of hepcidin-25 upon
iron injection in group A, pig 34 at days 3 (baseline), 14, 21 and 28.
doi:10.1371/journal.pone.0064022.g002
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different capital and small letters at P#0.01 and P#0.05,
respectively.
Results and Discussion
To assess the effect of different iron supplementation strategies
on the iron status and hepcidin levels in piglets, three different
protocols were employed. The control protocol involved two
injections (split supplementation) of piglets with 150 and 40 mg
Fe/kg b.w. on day 3 and 21 postpartum, respectively (group A), is
a routine iron therapy of piglets applied at the farm where the
study was performed. Our modified supplementation based on the
protocol recently described [10] involved two injections of
37.5 mg Fe/kg b.w. on day 3 and 14 postpartum (group B).
Piglets from the third group (group C) received 37.5 mg Fe/kg
b.w. on day 3 only. As shown in Table 1, iron supplementation in
group C was largely insufficient to maintain hematological
parameters and plasma iron status (Figure 3) till the weaning
(day 28). However, the rationale to include the latter group in this
study was to determine how long this single injection could
maintain the appropriate hematological status of piglets. Our
results clearly show that after day 21, the values of all
hematological parameters (except of RBC count) of piglets from
group C were significantly lower compared with those form group
A and B animals. Similarly, iron plasma parameters (Fe plasma
level, TIBC and Tf saturation) indicated gradually developing iron
deficiency in group C piglets. In contrast, RBC indices in animals
from group A and B were in the range of standard piglet
parameters in this age [22], [23]. Importantly, there were no
differences in most hematological indices between piglets from
group A and B throughout the experimental period. Significantly
lower values in piglets from group B were recorded only for MCV
on day 21 (P#0.01), HCT on day 28 (P#0.01) and MCHC on day
21 (P#0.05) (Table 1). Similar hematological status of group A
and B piglets strongly indicates that by applying a modified
protocol with decreased amounts of supplemental iron, a
satisfactory prophylactic effect preventing development of IDA
in piglets can be achieved till weaning. This observation extends
our previous results showing the efficacy of split supplementation
with reduced amounts of iron till day 14 after birth [10].
It is known that in iron deficiency, a drop of hematological
parameters is preceded by a decrease in plasma iron level, Tf iron
saturation and the increase in TIBC values [2]. This scenario was
perfectly reproduced in group C piglets: decrease in plasma iron
status recorded on day 14 resulted in a severe deterioration of
hematological status on day 21. In group B piglets, the plasma iron
status on day 14 was also found to be at the borderline of iron
deficiency (note that at that time piglets from both groups received
the same iron treatment), however, the second injection of iron to
group B piglets just at that day restored efficiently plasma iron
level and in consequence increased the values of most RBC
indices.
To assess the circulating levels of bioactive hepcidin in the
circulation of the piglets, we developed and validated a novel mass
spectrometry-based assay to quantifies hepcidin-25 in piglet
plasma samples (see Material and Methods section for details).
As shown in Figure 2, this methodology could detect the peptide
peak that corresponds to pig hepcidin-25 of (with molecular weight
of 2750 Dalton) in samples from group A piglets following
injection of the high dose of iron, but not at baseline. In fact, the
hepcidin-25 concentration in group A piglets showed in general a
gradual increase throughout the experimental period (Figure 4). In
contrast, the hepcidin-25 levels in plasma from group B and C
piglets remained just above or below the lower limit of
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quantification (,1 nM) of our assay throughout the experimental
period (Figures 4). The fact that we observe very low hepcidin
plasma concentration measured in all 3 day-old piglets at baseline
is surprising considering our previous finding of relatively high
abundance of hepatic hepcidin mRNA levels in piglets of the same
age, while no large increase in these liver mRNA levels were
observed upon iron intervention [10]. This discrepancy may relate
to an unknown hepcidin stimulus during early life in combination
with immature hepatic hepcidin maturation and secretion
pathways in these neonates [16] and shows the added value of
actually assessing the active circulating peptide. On the other
hand, the absence of circulating hepcidin-25 may relate to a
relative low sensitivity of the mass spectrometry assay compared to
mRNA quantification by real-time PCR in plasma from these
young piglets, although this was not found for mouse bioactive
hepcidin-25 [24]. Hepcidin concentration measured in plasma
from group A piglets markedly increased after the first injection of
high iron dose. Interestingly, in plasma of piglets supplemented
with 37.5 mg Fe/kg b.w. on day 3 (group B and C), hepcidin-25
was hardly detectable up to day 14. Moreover, even after the
second injection of iron dextran to piglets from group B on day 14,
plasma hepcidin-25 levels continued to be very low till weaning
(day 28). Notably, our methodology to quantify piglet hepcidin-25
yielded robust assay characteristics that were similar to those
published for hepcidin-25 in human plasma samples [17]. For
piglet hepcidin-25, intra-run coefficient of variations (CV) were
4.4% at 4.1 nM and 12.4% at 1.9 nM (n = 7), and inter-run CVs
were 6.3% at 3.3 nM and 7.4% at 4.8 nM (n = 8). Dilution
linearity of the piglet hepcidin-25 assay is shown in Figure S1
(R2 = 0.995).
Our results open an interesting field for speculations regarding
the relationship between iron supplementation, regulation of iron
metabolism and hematological status. Obviously, injection of high
amounts of iron rectifies neonatal IDA in pigs as exemplified in
this study and many others [10], [11], [12], [13]. However, it is
accompanied by the risk of excessive hepcidin synthesis, which in
turn may impair both the utilization of supplemental iron
deposited in RES macrophages and the absorption of dietary
iron. Our results clearly show that it is possible to strongly reduce
the amount of supplemental iron, and still maintain values of RBC
indices at the proper level without inducing hepcidin-25 expres-
sion. It is tempting to speculate that after injection of low doses of
supplemental iron to piglets according to our modified protocol,
iron is predominantly transferred to the bone marrow, where it
ensures the correct course of erythropoiesis. In contrast, in piglets
highly loaded with supplemental iron, iron is partially redistributed
to hepatocytes, where it induces hepcidin synthesis. Hepatic iron is
thought to induce hepcidin expression via bone morphogenetic
protein (BMP) signaling [25], [26]. On the other hand when serum
iron levels are low, transferrin receptor 1 (TfR1) sequesters HFE
Figure 3. Plasma iron parameters of piglets supplemented with iron dextran according to various protocols. A; plasma iron level. B;
total iron binding capacity. C; iron transferrin saturation. Values are expressed as the means 6 S.D. Plasma iron parameters were determined for 9
piglets from each experimental group. Different capital and small letters denote statistically significant difference at P#0.01 and P#0.05, respectively,
between parameters of piglets from different groups on a given day of experiment.
doi:10.1371/journal.pone.0064022.g003
Figure 4. Hepcidin concentration in blood plasma of piglets supplemented with iron dextran according to various protocols. Values
are expressed as the means 6 S.D. Hepcidin concentration was determined for 5–7 piglets from each group/day. Different capital and small letters
denotes statistically significant difference at P#0.01 and P#0.05, respectively, between parameters of piglets from different groups on a given day of
experiment.
doi:10.1371/journal.pone.0064022.g004
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on hepatocytes, preventing its interaction with transferrin receptor
2 (TfR2), which is necessary for signaling to hepcidin. As serum
iron saturation increases, HFE is displaced from its overlapping
binding site on TfR1 by holo-Tf. HFE is then freed to interact
with TfR2 and to signal for the increased production of hepcidin
[27,28]. Accordingly, after the first iron injection group A piglets
maintain in parallel permanent high plasma iron levels, high Tf
iron saturation and high hepcidin expression, which is then
intensified by the second injection of iron dextran on day 21. An
opposite relationship between iron plasma status and hepcidin
levels occurs in iron deficient piglets from group C. Piglets from
group B show an intermediate plasma iron status, which is
sufficient to fuel erythropoiesis but does not reach a threshold
indispensable for increasing plasma hepcidin levels.
Although our studies [10] demonstrate evident benefits of the
modified protocol of split supplementation of newborn piglets with
iron dextran, its usefulness in the swine industry may be limited
because of the necessity for a second iron dextran injection, which
makes this procedure labour-consuming and expensive. Our
present results provide a molecular background for planning mixt
parenteral/oral iron supplementation in newborn piglets. It seems
that early (on day 3) bolus parenteral supplementation with
reduced amount of iron dextran is indispensable because of the
extreme iron deficiency in newborn piglets and the high iron
demand for erythropoiesis. Keeping in mind that the injection to
piglets of ,40 mg Fe/kg b.w. does not induce hepcidin, we
hypothesize that the second phase of iron supplementation with
dietary iron starting on day 7–10 of life is an appropriate way to
satisfy the iron requirements of piglets more physiologically. We
have recently demonstrated that in piglets after day 4 postpartum,
the two duodenal iron transporters – DMT1 and ferroportin are
strongly expressed at their known site of activity in enterocytes
[10]. Although, the effectiveness of exclusive dietary iron
supplementation in improving hematological indices of piglets
has been recently confirmed on a large population of animals [29],
we still consider that the bolus administration of small amount of
iron on day 3 is a necessary component of piglet supplementation.
The concept of the innovative joined parenteral/oral supplemen-
tation of piglets with iron is now under investigation in our
laboratory.
Supporting Information
Figure S1 Dilution linearity of the piglet hepcidin-25
assay. A piglet plasma sample containing 8.3 nM (sample
content 1.00) Hepcidin-25 was diluted 2, 3, 5 and 10 times in
binding buffer (sample content 0.50, 0.33, 0.20 and 0.10,
respectively) and applied to WCX-TOF MS. The measured
hepcidin-25 values are indicated in nM. Dilution linearity:
R2 = 0.995.
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